GT Biopharma (GTBP) Preferred Dividend Payments (2025 - 2026)
GT Biopharma (GTBP) posted quarterly Preferred Dividend Payments of $433000.0 for Q1 2026, up 104.4% quarter-over-quarter from -$9.8 million in Q4 2025.
GT Biopharma (GTBP) Preferred Dividend Payments (2025 - 2026) Analysis & Trends
GT Biopharma (GTBP) has reported Preferred Dividend Payments for 2 consecutive years, with $433000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Dividend Payments changed N/A year-over-year to $433000.0; the TTM figure through Mar 2026 stood at -$5.3 million (changed N/A YoY), while the FY2025 annual figure was -$5.8 million, changed N/A from the prior year.
- Preferred Dividend Payments rose to $433000.0 in Q1 2026 per GTBP's latest filing, from -$9.8 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $4.1 million in Q3 2025 and bottomed at -$9.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - | 433,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 433,000.00 |
| Dec 31, 2025 | -9.83 Mn |
| Sep 30, 2025 | 4.06 Mn |
| Jun 30, 2025 | 85,000.00 |